Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • World View
  • Published:

Share the risks of Ebola vaccine development

Nature volume 519, page 263 (2015)Cite this article

Subjects

Ebola vaccines have little in the way of commercial markets, so the risks should be shared between governments and industry, says Seth Berkley.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Seth Berkley is chief executive of Gavi, the Vaccine Alliance, based in Geneva, Switzerland. This article is based on a TED talk delivered in Vancouver, Canada, on 18 March.,

    Seth Berkley

Authors
  1. Seth Berkley
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Seth Berkley.

Related links

Related links

Related links in Nature Research

Maternal health: Ebola’s lasting legacy 2015-Mar-04

Six challenges to stamping out Ebola 2015-Feb-24

Ebola: An eyewitness account from Sierra Leone 2014-Dec-02

Related external links

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berkley, S. Share the risks of Ebola vaccine development. Nature 519, 263 (2015). https://doi.org/10.1038/519263a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/519263a

Search

Advanced search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology